Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
NCT Number: NCT03832257
This prospective cohort study seeks to determine if the ECHO-CT program, a healthcare videoconferencing program, can improve clinical outcomes while reducing cost and resource utilization when expanded to a community hospital setting. Data will be analyzed on the facility level and patient level.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02215, United States
ECHO-Care Transitions is a healthcare outreach program utilizing videoconferencing technology to improve the quality and efficiency of care transitions for medically-complex elderly patients by connecting post-acute care facilities that receive BIDMC patients with a multidisciplinary BIDMC team that sends these patients following discharge. This case-control study seeks to determine if ECHO-CT can improve clinical outcomes and reduce cost and resource utilization during transitions of care in both an academic (BIDMC Boston) and community (BIDMC Needham) hospital.
Our prospective cohort study of the ECHO-CT intervention will take place in the two Boston-area hospitals, one providing tertiary care and one community-based care, in which the outcomes of patients transferred to Skilled Nursing Facilities (SNFs) associated with these hospitals will be compared to those transferred to SNFs from similar hospitals in New England. We will also be comparing outcomes from individual patients enrolled in the ECHO program to matched controls. Using a national database available from the Brown University Center for Gerontology and Healthcare Research, the outcomes of Medicare beneficiaries residing in SNFs that are participating in ECHO-CT will be compared to those in the comparison group using a difference-of-difference analytic approach. Analyses will be adjusted for potential confounders as appropriate.
In this study, the investigators also plan to measure satisfaction as well as process, utilization, cost and patient safety outcomes to determine best practices for implementing the program at a community hospital and affiliated SNFs.
Data will be obtained from the following sources:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Facility Inclusion Criteria:
Facility Exclusion Criteria:
Patient Selection:
ECHO-CT Group:
Inclusion criteria
Patients that were discharged from BIDMC and admitted to skilled nursing facilities that are participating in ECHO-CT between April 2019 and March 2021.
Exclusion criteria
Patients discharged from a hospital other than BIDMC. Patients admitted to a skilled nursing facility that is not participating in ECHO-CT.
Control Group:
Inclusion criteria
Patients from skilled nursing facilities not participating in ECHO.
Exclusion criteria
Patients discharged from BIDMC to one of our participating SNFs during the study period of April 2019- March 2021
weekly video conference between hospitalist and skilled nursing facilities
Matched Non-Participating Facilities
Time frame: 30-Days
Number of hospital readmissions over 30 day period among participating SNF sites
Time frame: up to 90 days
Includes average length of stay in the facility
Time frame: 30-days
Total 30-day Medicare costs for fee-for-service patients.
Beth Israel Deaconess Medical Center
Other
AHRQ Health Services Research Projects: Making Health Care Safer in Ambulatory Care Settings and Long Term Care Facilities
Acronym: ECHO-CT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03553069
Acute Disease, Critical Illness
Groningen, Netherlands
View Trial DetailsNCT06421246
Acute Disease, Disease Attributes
Hvidovre, Denmark
View Trial DetailsNCT05506683
Acute Disease, Disease Attributes
Accra, Accra Metropolitan District, Ghana
View Trial DetailsNCT05708768
Acute Disease, Chronic Disease
Fredrikstad, Akershus, Norway
View Trial Details